Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [15]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11079-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- IL-32 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated IL-32 antibody (Cat. #11079-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Spatial transcriptomics identifies IL-32 as a lipid droplet-associated cytokine linked to tubular injury in human diabetic kidney disease.
Subtype-specific NK cell-TAM interactions drive a novel prognostic signature in HNSCC.
Interleukin-32-expressing CD4(+) T cells are a potentially pathogenic subset in systemic sclerosis with interstitial lung disease.
Fusobacterium nucleatum and IL-32 co-predict nodal metastasis preoperatively in head and neck cancer.
Shared chemoresistance genes in ESCC and cervical Cancer: Insights from pharmacogenomics and Mendelian randomization.
IL-32 regulates trophoblast invasion through miR-205-NFκB-MMP2/9 axis contributing to the pregnancy-induced hypertension†.
Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology.
Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway.
Clinical implications of interleukins-31, 32, and 33 in gastric cancer.
Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells.
Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome.
IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway.
Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32.
Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32.
MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.
Meadows K, Chung H, Vo S, Imanzadeh A, Seo H, Belay SG, Swamy A, Teo W, Chapman K, Andonegui G, Benediktsson H, Stys PK, Pham T, Muruve DA, Chun J
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2026 Feb 7;75(1):33
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2026 Feb 7;75(1):33
Subtype-specific NK cell-TAM interactions drive a novel prognostic signature in HNSCC.
Zhao Z, Han X, Hu Y, Li Y, He Y, Wang Y, Yao Y, Li H, Wei J
Frontiers in immunology 2025;16:1676878
Frontiers in immunology 2025;16:1676878
Interleukin-32-expressing CD4(+) T cells are a potentially pathogenic subset in systemic sclerosis with interstitial lung disease.
Ishigaki S, Suzuki K, Kaneko Y
Respiratory investigation 2025 Sep;63(5):829-837
Respiratory investigation 2025 Sep;63(5):829-837
Fusobacterium nucleatum and IL-32 co-predict nodal metastasis preoperatively in head and neck cancer.
Wang Z, Huang H, Yuan X, Hsueh C, Zhang M
Translational cancer research 2025 Jun 30;14(6):3359-3372
Translational cancer research 2025 Jun 30;14(6):3359-3372
Shared chemoresistance genes in ESCC and cervical Cancer: Insights from pharmacogenomics and Mendelian randomization.
Liu Z, Liu J, Wu Y, Zhou Z, Ousmane D, Zeinalzadeh Z, Wang J
International immunopharmacology 2025 Feb 6;147:113933
International immunopharmacology 2025 Feb 6;147:113933
IL-32 regulates trophoblast invasion through miR-205-NFκB-MMP2/9 axis contributing to the pregnancy-induced hypertension†.
Liu J, Li W, Wang J, Bai L, Xu J, Chen X, Wang S, Li L, Xu X
Biology of reproduction 2024 Oct 14;111(4):780-799
Biology of reproduction 2024 Oct 14;111(4):780-799
Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology.
Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y
Journal of hepatocellular carcinoma 2022;9:389-403
Journal of hepatocellular carcinoma 2022;9:389-403
Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway.
Li Y, Wang Z
Experimental and therapeutic medicine 2022 Sep;24(3):567
Experimental and therapeutic medicine 2022 Sep;24(3):567
Clinical implications of interleukins-31, 32, and 33 in gastric cancer.
Liu QH, Zhang JW, Xia L, Wise SG, Hambly BD, Tao K, Bao SS
World journal of gastrointestinal oncology 2022 Sep 15;14(9):1808-1822
World journal of gastrointestinal oncology 2022 Sep 15;14(9):1808-1822
Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells.
Takagi K, Shimomura A, Imura J, Mori H, Noguchi A, Tanaka S, Minamisaka T, Nishida T, Hatta H, Nakajima T
Oncology letters 2022 Jan;23(1):14
Oncology letters 2022 Jan;23(1):14
Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome.
Hamzaoui K, Borhani-Haghighi A, Dhifallah IB, Hamzaoui A
Journal of neuroimmunology 2022 Apr 15;365:577820
Journal of neuroimmunology 2022 Apr 15;365:577820
IL-32 Promotes the Radiosensitivity of Esophageal Squamous Cell Carcinoma Cell through STAT3 Pathway.
Ma Z, Dong Z, Yu D, Mu M, Feng W, Guo J, Cheng B, Guo J, Ma J
BioMed research international 2021;2021:6653747
BioMed research international 2021;2021:6653747
Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32.
Wu K, Zeng J, Shi X, Xie J, Li Y, Zheng H, Peng G, Zhu G, Tang D, Wu S
Frontiers in pharmacology 2021;12:801493
Frontiers in pharmacology 2021;12:801493
Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32.
Takagi K, Imura J, Shimomura A, Noguchi A, Minamisaka T, Tanaka S, Nishida T, Hatta H, Nakajima T
Oncology letters 2020 Sep;20(3):2888-2896
Oncology letters 2020 Sep;20(3):2888-2896
MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.
He J, Ye W, Kou N, Chen K, Cui B, Zhang X, Hu S, Liu T, Kang L, Li X
Journal of cellular and molecular medicine 2020 Jan;24(1):841-849
Journal of cellular and molecular medicine 2020 Jan;24(1):841-849
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Transfected HEK-293 cells were subjected to SDS PAGE followed by western blot with 11079-1-AP( IL32 Antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The IL32 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human IL32. This antibody recognizes human antigen. The IL32 antibody has been validated for the following applications: ELISA, IHC, WB analysis.
